| Literature DB >> 17005453 |
Abstract
Pulmonary hypertension represents a significant disease burden in both the developed and developing worlds. Certain forms of pulmonary hypertension are more common in some countries than others but people of all races, all ages and both sexes are affected. Treatment options are limited and expensive. The development of new therapies will be determined by improved understanding of endothelial cell biology.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17005453 DOI: 10.1016/j.vph.2006.08.006
Source DB: PubMed Journal: Vascul Pharmacol ISSN: 1537-1891 Impact factor: 5.773